EW supply chain intelligence for Edwards Lifesciences Corporation: verified suppliers, customers, debt relationships, acquisitions, and ownership data.
Data compiled by Redley Lamar · ChainSifter Intelligence
Edwards Lifesciences Corporation (EW) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| INVESTEE | INVESTEE | 90% | In April 2021, the Company entered into a promissory note agreement and a subordinated convertible promissory note (collectively the “notes”), a preferred stock purchase agreement, and an option agre… |
| JENAVALVE-TECHNOLOGY-INC | JENAVALVE-TECHNOLOGY-INC | 90% | In January 2026, the Company invested in a convertible promissory note of $ 45.0 million in JenaValve Technology, Inc. pursuant to an Agreement and Plan of Merger executed in July 2024. |
| AUTUS | AUTUS | 85% | The Company exercised the option and accounted for the transaction as a step acquisition in accordance with authoritative guidance on accounting for business combinations. Accordingly, the previously… |
| MEDICAL-TECHNOLOGY-COMPANY | MEDICAL-TECHNOLOGY-COMPANY | 85% | In December 2024, the Company entered into an option agreement and an amended preferred stock purchase agreement with a medical technology company. |
| ALC | Alcon Inc. | 72% | Reciprocal relationship from ALC graph: Reciprocal relationship from EW graph: Reciprocal relationship from ALC graph: Reciprocal relationship from EW graph: Reciprocal relationship from ALC graph: R… |
| AVR | Anteris Technologies Global Corp. | 72% | Reciprocal relationship from AVR graph: Reciprocal relationship from EW graph: Reciprocal relationship from AVR graph: Reciprocal relationship from EW graph: Reciprocal relationship from AVR graph: m… |
| BDX | Becton, Dickinson and Company | 72% | Reciprocal relationship from BDX graph: Reciprocal relationship from EW graph: eering or other unauthorized access through the use of compromised credentials; exploitation of design flaws, bugs, or s… |
| BDX | Becton, Dickinson and Company | 72% | eering or other unauthorized access through the use of compromised credentials; exploitation of design flaws, bugs, or security vulnerabilities; intentional or unintentional acts by employees or othe… |
| MMSI | Merit Medical Systems, Inc. | 72% | Reciprocal relationship from MMSI graph: Item 2. “Properties.” We ship our products through distribution centers located in Virginia, Utah, Canada, Brazil, The Netherlands, United Kingdom (“UK”), Sou… |
| SNN | Smith & Nephew plc | 72% | Reciprocal relationship from SNN graph: idends and a share buyback of $500 million; – In addition, the Orthopaedics business has returned to growth; there has been improved inventory management; and … |
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| HOSPITAL-GROUP-PURCHASING-ORGANIZATIONS | HOSPITAL-GROUP-PURCHASING-ORGANIZATIONS | 90% | our corporate sales team actively pursues approval of Edwards Lifesciences as a qualified supplier for hospital group purchasing organizations |
| HEALTHCARE-SYSTEMS | HEALTHCARE-SYSTEMS | 85% | we have contracts with a number of United States and European national and regional buying groups, including healthcare systems |
| INTEGRATED-DELIVERY-NETWORKS | INTEGRATED-DELIVERY-NETWORKS | 85% | we have contracts with a number of United States and European national and regional buying groups, including healthcare systems and Integrated Delivery Networks |
| MEDICAL-TECHNOLOGY-COMPANY | MEDICAL-TECHNOLOGY-COMPANY | 80% | The Company had previously made an investment in preferred equity securities of the medical technology company under a prior preferred stock purchase agreement in 2021. |
| AVR | Anteris Technologies Global Corp. | 72% | Reciprocal relationship from AVR graph: market, and in particular the TAVR market. These markets are characterized by rapid change resulting from technological advances, innovations and scientific di… |
| BDX | Becton, Dickinson and Company | 72% | Reciprocal relationship from BDX graph: Reciprocal relationship from EW graph: Reciprocal relationship from BDX graph: Reciprocal relationship from EW graph: eering or other unauthorized access throu… |
| BDX | Becton, Dickinson and Company | 72% | eering or other unauthorized access through the use of compromised credentials; exploitation of design flaws, bugs, or security vulnerabilities; intentional or unintentional acts by employees or othe… |
| MMSI | Merit Medical Systems, Inc. | 72% | Reciprocal relationship from MMSI graph: Reciprocal relationship from EW graph: Reciprocal relationship from MMSI graph: Reciprocal relationship from EW graph: Reciprocal relationship from MMSI graph… |
| AORTIC-INNOVATIONS-LLC | AORTIC-INNOVATIONS-LLC | 62% | Price per Share February 2025 $ 250.0 2.6 $ 76.00 80 % July 2025 3.5 $ 71.06 August 2025 $ 500.0 5.1 $ 78.30 80 % September 2025 6.3 $ 79.05 February 2026 $ 500.0 4.7 $ 85.90 80 % April 2026 6.1 $ 81… |
| CARDIOVALVE-LTD | CARDIOVALVE-LTD | 62% | Price per Share February 2025 $ 250.0 2.6 $ 76.00 80 % July 2025 3.5 $ 71.06 August 2025 $ 500.0 5.1 $ 78.30 80 % September 2025 6.3 $ 79.05 February 2026 $ 500.0 4.7 $ 85.90 80 % April 2026 6.1 $ 81… |
| INNOVALVE-BIO-MEDICAL-LTD | INNOVALVE-BIO-MEDICAL-LTD | 62% | . Pursuant to the agreement, the Company may be required to invest up to an additional $ 3.0 million in the Investee's preferred equity securities and up to an additional $ 6.6 million for the option… |
| JC-MEDICAL-INC | JC-MEDICAL-INC | 62% | presented as the results of Innovalve are not material in relation to the consolidated financial statements of Edwards Lifesciences. Endotronix, Inc. On August 19, 2024, the Company acquired all the … |
| JENAVALVE-TECHNOLOGY-INC | JENAVALVE-TECHNOLOGY-INC | 62% | securities 5.5 — Carrying value of non-marketable equity securities 119.1 87.6 Total investments in unconsolidated entities $ 159.4 $ 121.2 66 Table of Contents EDWARDS LIFESCIENCES CORPORATION NOTES… |
| MAJOR-PRODUCT-GROUP | MAJOR-PRODUCT-GROUP | 62% | y environment, and product offerings. The Company's geographic segments are reported based on the financial information provided to the Chief Operating Decision Maker (“CODM”), which is the Company's… |
| VALTECH-CARDIO-LTD | VALTECH-CARDIO-LTD | 62% | Price per Share February 2025 $ 250.0 2.6 $ 76.00 80 % July 2025 3.5 $ 71.06 August 2025 $ 500.0 5.1 $ 78.30 80 % September 2025 6.3 $ 79.05 February 2026 $ 500.0 4.7 $ 85.90 80 % April 2026 6.1 $ 81… |
| VALTECH-SHAREHOLDER-REPRESENTATIVE-LLC | VALTECH-SHAREHOLDER-REPRESENTATIVE-LLC | 62% | Price per Share February 2025 $ 250.0 2.6 $ 76.00 80 % July 2025 3.5 $ 71.06 August 2025 $ 500.0 5.1 $ 78.30 80 % September 2025 6.3 $ 79.05 February 2026 $ 500.0 4.7 $ 85.90 80 % April 2026 6.1 $ 81… |
| Instrument | Description | Confidence | Evidence |
|---|---|---|---|
| EW-DEBT-7243 | Xbrl Convertible | 90% | xbrl convertible detail from xbrl 2008-12-31. |
| EW-DEBT | Debt stack $598.7M | 90% | Market cache reports total debt of $598.7M. |
| Holder | Name | Confidence | Evidence |
|---|---|---|---|
| EW-OWNER-BLACKROCK-INC | BlackRock, Inc. | 90% | 13F overlay lists BlackRock, Inc. as top holder; 1296 tracked holders. |
| Ticker | Name | Chain Index | Hops | Relationship Types |
|---|---|---|---|---|
| STAA | STAAR Surgical Company | 100.00 | 2 | |
| CDNA | CareDx, Inc. | 100.00 | 2 | |
| STQN | Strategic Acquisitions, Inc. | 100.00 | 2 | |
| AURX | Nuo Therapeutics, Inc. | 100.00 | 2 | |
| PYPD | PolyPid Ltd. | 100.00 | 2 | |
| NAUT | Nautilus Biotechnology, Inc. | 100.00 | 2 | |
| AORT | Artivion, Inc. | 100.00 | 2 | |
| MDWD | MediWound Ltd. | 100.00 | 2 | |
| COO | The Cooper Companies, Inc. | 100.00 | 2 | |
| DEO | Diageo plc | 100.00 | 2 | |
| BAX | Baxter International Inc. | 100.00 | 2 | |
| IINN | Inspira Technologies Oxy B.H.N. Ltd. | 100.00 | 2 | |
| BHC | Bausch Health Companies Inc. | 100.00 | 2 | |
| CUPR | Cuprina Holdings (Cayman) Limited | 100.00 | 2 | |
| ANGO | AngioDynamics, Inc. | 100.00 | 2 | |
| IHG | InterContinental Hotels Group PLC | 100.00 | 2 | |
| AVR | Anteris Technologies Global Corp. | 100.00 | 1 | ['customer', 'supplier'] |
| HBIO | Harvard Bioscience, Inc. | 100.00 | 2 | |
| EMBC | Embecta Corp. | 100.00 | 2 | |
| IART | Integra LifeSciences Holdings Corporation | 100.00 | 2 |